These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36100429)

  • 1. Zoledronic acid by subcutaneous infusion in palliative medicine.
    Ramdany H; Curtin J; Howard P
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e754-e755. PubMed ID: 36100429
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Intravenous Zoledronic Acid on Tibiofemoral Cartilage Volume Among Patients With Knee Osteoarthritis With Bone Marrow Lesions: A Randomized Clinical Trial.
    Cai G; Aitken D; Laslett LL; Pelletier JP; Martel-Pelletier J; Hill C; March L; Wluka AE; Wang Y; Antony B; Blizzard L; Winzenberg T; Cicuttini F; Jones G
    JAMA; 2020 Apr; 323(15):1456-1466. PubMed ID: 32315057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effect of intravenous infusion of zoledronic acid combined with oral medication of cinobufagin in the treatment of metastatic bone tumors.
    Wang T; Zhang L; Han L; Liu X; Zhang H; Zhang J; Yu H
    Pak J Pharm Sci; 2018 Jul; 31(4(Special)):1609-1612. PubMed ID: 30203746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quality improvement project to address the challenges surrounding zoledronic acid use in children.
    Weber DR; Diaz MCG; Louis S; Rackovsky N; Rahmani R; Stauber SD
    J Bone Miner Metab; 2021 Jul; 39(4):693-699. PubMed ID: 33825940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclizine continuous subcutaneous infusion in palliative medicine: practice survey.
    Virani F; Presland M
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e782-e783. PubMed ID: 37562926
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute Phase Reactions After Intravenous Infusion of Zoledronic Acid in Japanese Patients with Osteoporosis: Sub-analyses of the Phase III ZONE Study.
    Shiraki M; Kuroda T; Takeuchi Y; Sugimoto T; Tanaka S; Suzuki H; Hiraishi K; Nakamura T
    Calcif Tissue Int; 2021 Dec; 109(6):666-674. PubMed ID: 34247263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of palliative radiotherapy combined with zoledronic acid hydrate for metastatic bone tumour from renal cell carcinoma.
    Harada H; Shikama N; Wada H; Uchida N; Nozaki M; Hayakawa K; Yamada K; Nagakura H; Ogawa H; Miyazawa K; Katagiri H; Nakamura N
    Jpn J Clin Oncol; 2021 Jan; 51(1):100-105. PubMed ID: 32869095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
    Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
    Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of single dose intravenous zoledronic acid on bone mineral density in post-menopausal osteoporosis of Bangladeshi women.
    Hossain M; Chowdhury IH; Emran MA; Habib AH; Asaduzzamnan AK; Alam M; Ferdous C
    Bangladesh Med Res Counc Bull; 2010 Dec; 36(3):74-7. PubMed ID: 21548542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.
    Raje N; Terpos E; Willenbacher W; Shimizu K; García-Sanz R; Durie B; Legieć W; Krejčí M; Laribi K; Zhu L; Cheng P; Warner D; Roodman GD
    Lancet Oncol; 2018 Mar; 19(3):370-381. PubMed ID: 29429912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial.
    Barrett-Lee P; Casbard A; Abraham J; Hood K; Coleman R; Simmonds P; Timmins H; Wheatley D; Grieve R; Griffiths G; Murray N
    Lancet Oncol; 2014 Jan; 15(1):114-22. PubMed ID: 24332514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases.
    Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
    Quintessence Int; 2016; 47(5):433-40. PubMed ID: 26665262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
    Reid DM; Devogelaer JP; Saag K; Roux C; Lau CS; Reginster JY; Papanastasiou P; Ferreira A; Hartl F; Fashola T; Mesenbrink P; Sambrook PN;
    Lancet; 2009 Apr; 373(9671):1253-63. PubMed ID: 19362675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneously recovered severe thrombocytopaenia following zoledronic acid infusion for osteoporosis.
    Kulkarni P; Cushman T; Donthireddy V; Rao S
    BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26843222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis.
    Koldkjær Sølling AS; Harsløf T; Langdahl B
    Osteoporos Int; 2019 May; 30(5):995-1002. PubMed ID: 30656367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a multicenter open-label randomized trial evaluating infusion duration of zoledronic acid in multiple myeloma patients (the ZMAX trial).
    Berenson JR; Boccia R; Lopez T; Warsi GM; Argonza-Aviles E; Lake S; Ericson SG; Collins R
    J Support Oncol; 2011; 9(1):32-40. PubMed ID: 21465735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients - ZAP2.
    Aitken D; Laslett LL; Cai G; Hill C; March L; Wluka AE; Wang Y; Blizzard L; Cicuttini F; Jones G
    BMC Musculoskelet Disord; 2018 Jul; 19(1):217. PubMed ID: 30021646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial.
    Goenka S; Sethi S; Pandey N; Joshi M; Jindal R
    Spinal Cord; 2018 Dec; 56(12):1207-1211. PubMed ID: 30258212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women.
    Lambrinoudaki I; Vlachou S; Galapi F; Papadimitriou D; Papadias K
    Clin Interv Aging; 2008; 3(3):445-51. PubMed ID: 18982915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Tubular Necrosis Caused by Zoledronic Acid Infusion in a Patient With Osteoporosis.
    Jani C; Ueberroth J; Page S; Sehra S
    Am J Ther; 2021 Apr; 29(1):e146-e148. PubMed ID: 34010158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.